ACHILLES TX LIMITED AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 1st, 2021 • Achilles Therapeutics PLC • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 1st, 2021 Company Industry JurisdictionTHIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered on the ___ day of February 2021, by and among ACHILLES TX LIMITED (Company no. 13027460) (the “Company”), ACHILLES THERAPEUTICS UK LIMITED (Company no. 10167668) (“ATUK”), CANCER RESEARCH TECHNOLOGY LIMITED (“CRT”) (Company no. 01626049) and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor” (together, the “Parties”).
ACHILLES THERAPEUTICS LIMITED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 8th, 2021 • Achilles Therapeutics LTD • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 8th, 2021 Company Industry JurisdictionTHIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the day of November 2020, by and among ACHILLES THERAPEUTICS LIMITED (the “Company”) (Company no. 10167668), CANCER RESEARCH TECHNOLOGY LIMITED (“CRT”) (Company no. 01626049) and the investors listed on Exhibit A hereto, referred to hereinafter as the “Investors” and each individually as an “Investor”.